Coronary Thrombosis in a Patient with COVID-19 Who Was on Anticoagulant Therapy

Authors

Mohammad Reza HatamnejadMohammad Reza Hatamnejad ORCID1, Farima Fallah Tafti1, Ali Abdi ardekani2, Shahrokh Sadeghi BoogarShahrokh Sadeghi Boogar ORCID3, Hamed Bazrafshan DrissiHamed Bazrafshan Drissi ORCID2,*
1Faculty of Medicine, Shiraz University of Medical Sciences, Shiraz, IR Iran
2Cardiovascular Research Center, Shiraz University of Medical Sciences, Shiraz, IR Iran
3Department of Internal Medicine, Shiraz University of Medical Science, Shiraz, IR Iran
*Corresponding Author: Al-Zahra Charity Hospital, Department of Cardiology Medicine, Shiraz University of Medical Sciences, Zand St, Shiraz, Iran. PO Box: 71348-14336. Tel: +98-9177120900, E-mail: [email protected]. Email: [email protected]

International Cardiovascular Research Journal:Vol. 15, issue 3; e114520
Published online:Sep 01, 2021
Article type:Case Report
Received:Mar 09, 2021
Accepted:Jul 06, 2021
How to Cite:Hatamnejad MR, Fallah Tafti F, Abdi ardekani A, Sadeghi Boogar S, Bazrafshan Drissi H. Coronary Thrombosis in a Patient with COVID-19 Who Was on Anticoagulant Therapy. Int Cardiovasc Res J. 2021;15(3):e114520. doi:

Abstract

Introduction: COVID-19-related thrombotic events are associated with an increase in the risk of mortality and morbidity. Considering the research on the pathophysiology of the disease, the significance of cardiac thrombosis is being more recognized.
Case Presentation: This study aimed to present the first case report of a Left Main Coronary Artery (LMCA) thrombosis due to COVID-19 infection in a middle-aged male with a mechanical valve on anticoagulant therapy and with an International Normalized Ratio (INR) within the therapeutic range.
Conclusions: The results suggested that the therapeutic INR range may need to be higher (about 3.5) during the acute phase of COVID-19 infection to prevent thrombotic events amongst patients with COVID-19 who are on anticoagulant therapy. However, further evidence is required to determine the target range for INR in patients with COVID-19 who are on anticoagulants prior to infection.
 

Fulltext

The full-text is available in pdf.

References

  • 1.
    The references are available in pdf.

Copyright

© 2021, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.

Similar Articles

15
Mar
2021

A Case of Multiple Large Left Ventricular Clots in a Patient with COVID-19

Azin Alizadehasl,
Soudeh Roudbari,
Pegah Salehi,
Alireza Sistani,
Atousa Mostafavi,
Hossein Kamranzadeh Fumani
,et al.

Alizadehasl A, Roudbari S, Salehi P, Sistani A, Mostafavi A, et al. A Case of Multiple Large Left Ventricular Clots in a Patient with COVID-19. Int Cardiovasc Res J. 2021;15(1):e107642. doi:

27
Oct
2024
Simultaneous Type A Aortic Dissection, Pulmonary Thromboembolism, and Deep Vein Thrombosis in a COVID-19 Patient: A Case Report Study

Simultaneous Type A Aortic Dissection, Pulmonary Thromboembolism, and Deep Vein Thrombosis in a COVID-19 Patient: A Case Report Study

Sayed Mohammad Reza Abtahi,
Azin Alizadehasl,
Mahdi Khalili

Abtahi SMR, Alizadehasl A, Khalili M. Simultaneous Type A Aortic Dissection, Pulmonary Thromboembolism, and Deep Vein Thrombosis in a COVID-19 Patient: A Case Report Study. Arch Clin Infect Dis. 2024;19(5):e148203. doi: https://doi.org/10.5812/archcid-148203

22
May
2023

Thrombotic or Thromboembolic Events in COVID-19: A Literature Review

Reza Shojaee,
Saeed Karimi Matloub,
Rasool Karimi Matloub

Shojaee R, Karimi Matloub S, Karimi Matloub R. Thrombotic or Thromboembolic Events in COVID-19: A Literature Review. Ann Mil Health Sci Res. 2022;20(4):e134672. doi: https://doi.org/10.5812/amh-134672

22
Aug
2022
Thrombotic Presentation of MIS-C After COVID-19 Infection in a Nine-Year-Old Boy

Thrombotic Presentation of MIS-C After COVID-19 Infection in a Nine-Year-Old Boy

Abdollah Karimi,
Ilia Mirzaei,
Saeedeh Yaghoubi

Karimi A, Mirzaei I, Yaghoubi S. Thrombotic Presentation of MIS-C After COVID-19 Infection in a Nine-Year-Old Boy. Arch Pediatr Infect Dis. 2023;11(1):e127250. doi: https://doi.org/10.5812/pedinfect-127250

26
Jan
2022
Coagulation Disorders in Hospitalized COVID-19 Patients and Relationship with Disease Outcome: A Cross-sectional Study

Coagulation Disorders in Hospitalized COVID-19 Patients and Relationship with Disease Outcome: A Cross-sectional Study

Shafagh Aliasgarzade,
Somaieh Matin,
Nazli Javaheri,
Javad Aliasgarzade,
Vahideh Aghamohammadi

Aliasgarzade S, Matin S, Javaheri N, Aliasgarzade J, Aghamohammadi V. Coagulation Disorders in Hospitalized COVID-19 Patients and Relationship with Disease Outcome: A Cross-sectional Study. Arch Clin Infect Dis. 2021;16(5):e114213. doi: https://doi.org/10.5812/archcid.114213

More by these authors

Mohammad Reza HatamnejadPubMedScholar
Farima Fallah TaftiPubMedScholar
Ali Abdi ardekaniPubMedScholar
Shahrokh Sadeghi BoogarPubMedScholar
Hamed Bazrafshan DrissiPubMedScholar
Share
Cited by
Metrics
Indexed in